Andrea Costantini
      OUR PEOPLE

      Dr. Andrea Costantini

      MD specialized in Clinical Pharmacology

      Director Scientific Engagement Americas

      Contact

      Andrea is Director Scientific Engagement Americas. She holds an MD specialized in Clinical Pharmacology from the University of Buenos Aires. Prior to joining PMI in 2019, Andrea worked in the pharmaceutical industry for Roche, GSK, and Novartis, among other companies. There, she held numerous roles, including in Medical Affairs: Medical Information, Pharmacovigilance, as a Medical & Scientific Communications Manager, and Head of Emerging Markets West Content Hub.

      Andrea developed expertise in respiratory medicine (mainly asthma and Chronic Obstructive Pulmonary Disease (COPD), clinical research, bioequivalence and non-inferiority trials, pharmacovigilance, medical governance, scientific engagement, and leadership. She is the author of several posters presented at international conferences.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.